Watch Ticker

Inhibrx, Inc. Common Stock

Go to Inhibrx, Inc. Common Stock Website

$21.32

0.38 (1.82%)

Live

Previous Close

$20.935

Day Range

$20.93 - $21.4

Previous Day Range

$20.76 - $23.0274

Market Cap

$315.6 million USD

Day Vol.

3747

Previous Day Vol.

120690

Currency

USD

Primary Exchange

Nasdaq

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates inc...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Emilio Ghigini - Inhibrx stock rated 'Market Perform' by JMP after Sanofi acquisition - Investing.com

JMP Securities initiated coverage on Inhibrx Inc. with a Market Perform rating following the acquisition of INBRX-101 by Sanofi. The newly formed Inhibrx Biosciences has a strong financial foundation, but faces challenges with negative profitability metrics.

Related tickers: INBX, SNY.

Read Full Article

Zacks Equity Research - Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates

Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -61.68% and 1,534%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: INBX, VCEL.

Read Full Article

Trending Tickers

Please sign in to view